Muteins of hngf, therapeutic uses and pharmaceutical compositions
EP1893649A2
Method for the potentiation of opioid analgesics effects on pain
EP1871427A2
Use of nothobranchius furzeri as a model system for the characterization of drugs that control ageing
AU2005238317A1
Non human transgenic animal as a model of neurodegenerative diseases and for the early diagnosis thereof
CN101724070A
Humanized anti-NGF antibodies
EP1682170A2
Compositions able to prevent neurodegenerative processes and methods of assaying the same
IL164500D0
2,5-Bis-diamine-Ä1,4Übenzoquinonic derivatives, useful for the treatment of alzheimers disease, method for disease, method for preparing them and intermediates of said method
WO0073344A2
Monoclonal antibodies, synthetic and biotechnological derivatives thereof acting as ngf-antagonist molecules
